These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios. Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Triebwasser JE; Gerber JS; Morris JS; Weirick ME; McAllister CM; Bolton MJ; Arevalo CP; Anderson EM; Goodwin EC; Hensley SE; Puopolo KM JAMA Pediatr; 2021 Jun; 175(6):594-600. PubMed ID: 33512440 [TBL] [Abstract][Full Text] [Related]
6. Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies. Poon LC; Leung BW; Ma T; Yu FNY; Kong CW; Lo TK; So PL; Leung WC; Shu W; Cheung KW; Moungmaithong S; Wang CC Ultrasound Obstet Gynecol; 2021 Jun; 57(6):974-978. PubMed ID: 33798280 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Anti-SARS-CoV-2-Specific Antibody Signatures in Maternal and Infant Blood after COVID-19 Infection versus COVID-19 Vaccination during Pregnancy. Sabharwal V; Taglauer E; Demos R; Snyder-Cappione J; Shaik-Dasthagirisaheb YB; Parker-Kelleher S; Hunnewell J; Boateng J; Clarke K; Yuen R; Barnett ED; Wachman EM; Yarrington CD Am J Perinatol; 2024 May; 41(S 01):e2970-e2977. PubMed ID: 37774748 [TBL] [Abstract][Full Text] [Related]
8. Maternal-infant transfer of SARS-CoV-2 antibodies following vaccination in pregnancy: A prospective cohort study. Korchinski I; Marquez C; McClymont E; Av-Gay G; Andrade J; Elwood C; Jassem A; Krajden M; Morshed M; Sadarangani M; Tanunliong G; Sekirov I; Money D Vaccine; 2024 Nov; 42(25):126123. PubMed ID: 38981741 [TBL] [Abstract][Full Text] [Related]
9. Effects of the timing of maternal SARS-CoV-2 infection and vaccination status on placental transfer of antibodies to neonates: A cross-sectional study. Zhang D; Liu S; Peng B; Shi X; Weng T; Fang D; Lu L; Meng X; Xiong H; Zhang X; Qu J; Zhong J; Wang P Int J Infect Dis; 2024 Sep; 146():107098. PubMed ID: 38762044 [TBL] [Abstract][Full Text] [Related]
10. Maternal and Cord Anti-SARS-CoV-2-Spike IgG following COVID-19 Vaccination versus Infection during Pregnancy: A Prospective Study, Israel October 2021-March 2022. Abu Shqara R; Frank Wolf M; Mikhail Mustafa S; Sgayer I; Assulyn T; Abu Zraki A; Askhar Majadla N; Rechnizter H; Shehadeh M; Fleisher Sheffer V; Bordeynik-Cohen M; Yakir O; Lowenstein L; Sela E; Edelstein M; Dror AA Am J Perinatol; 2024 May; 41(S 01):e1935-e1943. PubMed ID: 37164317 [TBL] [Abstract][Full Text] [Related]
11. Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine. Beharier O; Plitman Mayo R; Raz T; Nahum Sacks K; Schreiber L; Suissa-Cohen Y; Chen R; Gomez-Tolub R; Hadar E; Gabbay-Benziv R; Jaffe Moshkovich Y; Biron-Shental T; Shechter-Maor G; Farladansky-Gershnabel S; Yitzhak Sela H; Benyamini-Raischer H; Sela ND; Goldman-Wohl D; Shulman Z; Many A; Barr H; Yagel S; Neeman M; Kovo M J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34014840 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 anti-RBD and anti-N protein responses are differentially regulated between mother-child pairs: insight from a national study cohort at the Faroe Islands. Jarlhelt I; Hansen CB; Pérez-Alós L; Weihe P; Petersen MS; Garred P Front Immunol; 2024; 15():1418678. PubMed ID: 39021574 [TBL] [Abstract][Full Text] [Related]
13. Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study. Rottenstreich A; Zarbiv G; Oiknine-Djian E; Vorontsov O; Zigron R; Kleinstern G; Wolf DG; Porat S Clin Microbiol Infect; 2022 Mar; 28(3):419-425. PubMed ID: 34740773 [TBL] [Abstract][Full Text] [Related]
14. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery. Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127 [TBL] [Abstract][Full Text] [Related]
15. Kinetics of Maternally Derived Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in Infants in Relation to the Timing of Antenatal Vaccination. Rottenstreich A; Zarbiv G; Oiknine-Djian E; Vorontsov O; Zigron R; Kleinstern G; Porat S; Wolf DG Clin Infect Dis; 2023 Feb; 76(3):e274-e279. PubMed ID: 35717644 [TBL] [Abstract][Full Text] [Related]
16. Maternal Antibody Response, Neutralizing Potency, and Placental Antibody Transfer After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Joseph NT; Dude CM; Verkerke HP; Irby LS; Dunlop AL; Patel RM; Easley KA; Smith AK; Stowell SR; Jamieson DJ; Velu V; Badell ML Obstet Gynecol; 2021 Aug; 138(2):189-197. PubMed ID: 33910220 [TBL] [Abstract][Full Text] [Related]
17. The Effect of Gestational Age at BNT162b2 mRNA Vaccination on Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Levels. Rottenstreich A; Zarbiv G; Oiknine-Djian E; Vorontsov O; Zigron R; Kleinstern G; Wolf DG; Porat S Clin Infect Dis; 2022 Aug; 75(1):e603-e610. PubMed ID: 35171998 [TBL] [Abstract][Full Text] [Related]
18. Maternal-Fetal Immunologic Response to SARS-CoV-2 Infection in a Symptomatic Vulnerable Population: A Prospective Cohort. Larcade R; DeShea L; Lang GA; Caballero MT; Ferretti A; Beasley WH; Tipple TE; Vain N; Prudent L; Lang ML; Polack FP; Ofman G J Infect Dis; 2022 Mar; 225(5):800-809. PubMed ID: 34865064 [TBL] [Abstract][Full Text] [Related]
19. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C). Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033 [TBL] [Abstract][Full Text] [Related]
20. Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History. Tarkowski M; de Jager W; Schiuma M; Covizzi A; Lai A; Gabrieli A; Corbellino M; Bergna A; Ventura CD; Galli M; Riva A; Antinori S Front Immunol; 2021; 12():793191. PubMed ID: 34975897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]